GlassScriptPhysician profile
Theodore J Suchy
NPI 1568410546
$3,576.31
in general payments reported to CMS, 2019-2025
34 companies · $272 in 2025
The $272 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $868 · 2020: $203 · 2021: $580 · 2022: $676 · 2023: $651 · 2024: $327 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,250.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $621.01 | 2019-2025 | Journey II, Aetos Shoulder System, Bone Anchors With Arthroscopic Delivery System |
| Electronic Waveform Lab, INC. | $547.91 | 2019-2022 | |
| Catalyst Orthoscience | $260.98 | 2021-2024 | Catalyst Csr Shoulder System |
| Abbott Laboratories | $241.87 | 2019-2024 | Proclaim |
| Fidia Pharma USA INC. | $233.77 | 2019-2025 | Hymovis, Triluron, Hyalgan |
| Avanos Medical | $182.08 | 2022-2024 | Genvisc 850 Sodium Hyaluronate |
| Pacira Pharmaceuticals Incorporated | $141.81 | 2023-2025 | Exparel, Zilretta, Iovera |
| Orthogenrx INC. | $130.21 | 2019-2021 | |
| Horizon Therapeutics Plc | $112.55 | 2019-2020 | |
| Depuy Synthes Sales INC. | $100.16 | 2019-2023 | Orthovisc, Monovisc |
| Organogenesis INC. | $93.19 | 2022-2024 | Puraply |
| Bioventus LLC | $73.31 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $71.77 | 2019-2023 | Tricera Handpiece |
| Orthofix Medical, INC. | $65.90 | 2024-2025 | Physio-Stim, Accelstim |
| Sanara Medtech INC. | $63.96 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trice Medical, INC. | $61.10 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $54.27 | 2023 | Seglentis |
| Endo Pharmaceuticals INC. | $53.89 | 2019-2024 | Xiaflex |
| Heron Therapeutics, INC. | $53.05 | 2023 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $51.23 | 2024-2025 | |
| Vericel Corporation | $48.06 | 2019 | |
| Amgen INC. | $45.92 | 2019 | |
| Ferring Pharmaceuticals INC. | $38.18 | 2021-2025 | Euflexxa |
| Heraeus Medical, LLC. | $36.37 | 2025 | |
| Sanofi-Aventis U.S. LLC | $32.23 | 2022-2023 | |
| Ibsa Pharma INC. | $25.62 | 2022 | |
| Curonix LLC | $22.33 | 2022 | |
| Kerecis Limited | $21.62 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Pfizer INC. | $20.00 | 2019 | |
| Convatec INC. | $17.19 | 2022 | |
| Checkpoint Surgical, INC | $15.63 | 2023 | Checkpoint Stimulators |
| Davol INC. | $13.58 | 2023 | |
| Medtronic USA, INC. | $13.41 | 2019 | |
| Intellijoint Surgical INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Suchy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.